Stay informed with the latest updates for the inheritable blood disorders community.

          Industry
          FDA Accepts License Application and Grants Priority Review for Emicizumab
          FDA Accepts License Application and Grants Priority Review for Emicizumab…
          NBDF & Community
          7 Ways You Can Prepare for Emergencies
          7 Ways You Can Prepare for Emergencies
          Industry
          Alnylam Reports Patient Death in Fitusiran Clinical Study
          Alnylam Reports Patient Death in Fitusiran Clinical Study
          Industry
          Bayer Submits Application for Long-Acting FVIII Candidate
          Bayer Submits Application for Long-Acting FVIII Candidate
          Medical
          Genetics of Hemophilia the Focus of New Partners Module
          Genetics of Hemophilia the Focus of New Partners Module
          Industry
          Sangamo and Pfizer Announce First Patient Treated in Hemophilia A Gene Therapy Trial
          Sangamo and Pfizer Announce First Patient Treated in Hemophilia…
          Industry
          FDA Approves Additional Vial Sizes for Nuwiq®
          Medical
          FDA Accepts License Application and Grants Priority Review for Emicizumab
          FDA Approves New Combination Therapy for all Major Hepatitis C Genotypes
          Industry
          Pfizer to Build Gene Therapy Facility in North Carolina
          Pfizer to Build Gene Therapy Facility in North Carolina
          NBDF & Community
          Leading Bleeding Disorders Advocacy Organizations File Hemophilia Discrimination Complaint Against Wellmark Blue Cross and Blue Shield
          Leading…
          Industry
          Spark Reports Preliminary Data from Hemophilia A Gene Therapy Trial
          Spark Reports Preliminary Data from Hemophilia A Gene Therapy Trial
          Medical
          New Medscape Activity Looks at Integrating Extended Half Life Products into Clinical Practice
          New Medscape Activity Looks at Integrating Extended…
          Medical
          FDA Expands Labeling for Epclusa® to Include Co-Infected Patients with HCV/HIV and Warning for HBV Reactivation
          FDA Expands Labeling for Epclusa® to…
          Medical
          Genetics of Hemophilia the Focus of New Partners Module
          Newly Launched Partners Module Provides Knowledge of von Willebrand…
          Industry
          UniQure Escalates Hemophilia B Gene Therapy Manufacturing Site
          UniQure Escalates Hemophilia B Gene Therapy Manufacturing Site